Open
SectorHealthcare
53.13 1.3
24h
Min
51.8
Max
53.7
Income | -16M -184M |
---|---|
Sales | -6.1M 111M |
Profit margin | -166.199 |
Employees | 725 |
EBITDA | -17M -143M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +24.35% upside |
Next Earnings | 10 lis 2025 |
---|
Market Cap | 866M 9.9B |
---|---|
Previous open | 51.83 |
Previous close | 53.13 |
By Acuity
82%
18%
352 / 371 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 66.5 USD 24.35%
High 82 USD
Low 56 USD
Based on 17 Wall Street analysts offering 12 month price targets forBridgebio Pharma Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$